Skip to main content

GeneXpert analysis of bronchoalveolar lavage (BAL) samples: promising diagnostic modality in patients with smear-negative pulmonary tuberculosis

Abstract

Purpose

The aim of the study is to assess the diagnostic utility of bronchoalveolar lavage (BAL) samples with GeneXpert test in diagnosis of TB in smear-negative patients.

Method

One-hundred sixty-nine cases were included in this study, as they had a radiological finding suggested to have pulmonary tuberculosis, while the sputum direct smear examination for acid-fast bacilli was negative. All cases prepared to do fiber-optic bronchoscope with bronchoalveolar lavage collection after their consent and post bronchoscope sputum collection for further molecular and microbiological examination.

Results

The combined diagnostic yield of all bronchoscopy procedures was 15.97% (27 cases of 169) and the final diagnosis of TB cases was established in 16 cases of 169 (9.4%) using BAL culture and in 20 cases of 169 (11.83%) by GeneXpert methods. Post bronchoscope direct sputum examination, culture, and GeneXpert evaluation gave diagnostic yield about 1.1%, 5.5%, and 7.1%, respectively. The specificity of GeneXpert examination of BAL and post bronchoscope sputum was 95.42% and 97.38%, respectively.

Conclusion

Early detection of pulmonary tuberculosis using fiber-optic bronchoscope BAL examination and post bronchoscope sputum with GeneXpert method promotes the accurate decision to start antituberculous therapy in patients with smear negative.

Introduction

Tuberculosis as a contagious disease is one of the most common causes of death worldwide [1]; the annual incidence of active pulmonary TB reached to 9.4 million, with mortality incidence about 137 cases per 100,000 populations [2]. TB is a disease of poverty and low-income people; therefore, the highest prevalence countries for TB were located in Asia, mainly in India [3]. Although in developed and high-income countries the health agenda about TB problem is disappeared, the concern is re-emerged in the last few decades because of migration [4, 5]. Kuwait country is located at the northern end of the Arabian Gulf [6]. The ratio of Kuwaitis:non-Kuwaiti’s people is 1:2.5, and it is considered as a good example for migration health-associated infectious disease like TB [4, 6,7,8]. The Kuwait National Tuberculosis Programmed started in 1954, and it worried about screening of TB using tuberculin skin test and radiography; subsequently, the suspected individuals undergo sputum examination using direct smear evaluation and culture to start the specialized antituberculous therapy [4, 6]. However, a considerable proportion of pulmonary TB patients is presented with negative sputum, which ranged from 20 to 60% [9]. The proper diagnosis of TB patients with smear negative is a great challenge toward clinician, to avoid progression to active disease if untreated, or unnecessary empirical antituberculous therapy [10,11,12,13]. Currently, several modalities are available to diagnose such cases with different yields and risk association, as sputum induction by hypertonic saline, gastric lavage especially in children, transthoracic needle aspiration, and fiber-optic bronchoscopy (FOB) [11, 14]. The diagnostic utility of FOB and its associated procedures as bronchoalveolar lavage and bronchial brushes is higher in detection of pulmonary infection, and in spite of it is considered as an invasive procedure, it has been proven to be safe with fewer complications in highly skilled hands [14,15,16,17]. From that point of view, the primary aim of the work was to evaluate the diagnostic yield of bronchoalveolar lavage culture and GeneXpert, as well as post bronchoscope sputum examination in suspected patients with smear-negative tuberculosis.

Patients and methods

Patients and study type

This is a retrospective cohort study, which was conducted on Pulmonary Rehabilitation Center, Chest Hospital, Kuwait City, and included 169 participants with radiological and clinical features that suggested pulmonary tuberculosis infection irrespective with negative smear for acid fast bacilli (AFB), in the period from January 2019 to January 2020. The data of corresponding cases were extracted from hospital medical records after approval of ethical committee member no. 1394/2020. The study included all cases that were subjected to fiber-optic bronchoscope with collection of bronchoalveolar lavage (BAL) and post bronchoscope sputum sample. The age of participants was above 18 years and below 65 years, and all of them were free from chronic lung disease, advanced lung cancer, or any type of respiratory failure.

Data collection

The following data had been extracted from medical records and included (1) demographic characteristics as age, sex, nationality, smoking habits, and occupation, (2) radiological examination using X-ray, and (3) laboratory investigation including complete cell counts, liver function test, and kidney function.

Bronchoscopy

The bronchoscopic procedure steps were fulfilled as regarding the guideline protocol of Bronchoscopy Unit of Chest Hospital; hence, the cases were assessed clinically and signed informed consent about flexible fiber-optic bronchoscope. The bronchoscope was performed through oral or nasal route in supine position under intravenous conscious sedation. All patients were under continuous monitoring of blood pressure and oxygen saturation. After complete inspection of the bronchial tree, BAL was done with 120 ml of normal saline at the suspected region. The patients had been observed in the recovery room for 2 h after procedure and follow up by chest x-ray PA view before discharge from our bronchoscopy unite. BAL samples and post bronchoscopy sputum samples were sent for AFB smear and culture, gram stain and culture, and GeneXpert PCR for evaluation.

Sputum evaluation

  1. 1-

    Microscopic examination

Sputum sample is prepared as regarding the clinical protocol of microscopic examination of mycobacterium tuberculosis; after that, the sample was stained by Ziehl–Neelsen carbolfuchsin (ZN) stain [18].

  1. 2-

    GeneXpert examination

The collected samples were subjected to GeneXpert examination as regarding the manufacture guideline protocol of preparation [19].

  1. 3-

    Sample culture

The collected samples were subjected to culture on solid media (Lowenstein–Jensen media), which is considered as gold standard test for detection of MTB; the culture time ranged from 6 to 8 weeks [20].

Statistical analysis

Statistical analysis was performed by Minitab 17.1.0.0 for windows (Minitab Inc., 2013, Pennsylvania, USA). The normality of data was examined using Shapiro–Wilk test. Continuous data was presented as mean and standard deviation (SD) while categorical data as number and percentage (%). Sensitivity and specificity were estimated from the equation as follows: “sensitivity = (true positive cases/(true positive cases + false-negative cases) and specificity = (true negative cases/(true negative cases + false-positive cases).” However, positive and negative predictive values depend on the prevalence of the disease in the population of interest and result from equation as follows: “positive predictive value = (true positive cases/(true positive cases + false-positive case) and negative predictive value = (true negative cases/(true negative cases + false-negative cases).” The accuracy of test with binary classification was the result from the grand equation: (true positive + true negative)/(true positive + true negative + false-positive + false negative). All tests were two sided; P is considered significant if < 0.05.

Results

General and clinical characteristic of cases

About 169 cases had changes in X-ray as well as symptoms suggested pulmonary tuberculosis; all of them had negative sputum direct microscopic examination for AFB in addition to GeneXpert examination test for sputum. The general and clinical criteria of suspected cases were summarized in Table 1; hence, the mean (SD) age of them was 44 (9) years, with male sex predominance (85.21%) and non-Kuwaiti nationality (97.63%).

Table 1 General characteristics and clinical presentation of patients

Fiber-optic bronchoscope with bronchoalveolar lavage (BAL)

The common gross features abnormality that is detected by bronchoscope was mucosal edema of tracho-bronchial tree (100 cases of 169) and narrowing in some segmental bronchus (40 cases of 169). Post bronchoscopic direct smear examination was positive for AFB in only 2 cases of 169, which has the lower diagnostic yield for TB recognition. However, the GeneXpert test for post bronchoscopic sputum and BAL sample was positive in 12 and 20 cases of 169 respectively, which enhance the diagnostic yield up 7.1% and 11.83, respectively. Moreover, the rate of pulmonary TB in patients with negative sputum increased up to 5.33% and 9.47% respectively after culture of post bronchoscopic sputum and BAL sample. The overall diagnostic utility of all fiber-optic bronchoscope technique in identifying TB infection increased to 15.97% (Table 2).

Table 2 Diagnostic yield of fiber-optic bronchoscopic technique

The specificity and accuracy of all diagnostic tests after fiber-optic bronchoscope were more than 90% (Table 3).

Table 3 Utility of GeneXpert and post bronchoscope sputum examination

Discussion

The current study included 169 cases with radiological evidence suggested pulmonary TB infection; however, three-sputum sample direct smear and GeneXpert were negative. All of them subjected to fiber-optic bronchoscope with BAL for further microbiological and molecular evaluation for TB. Bronchoscopic examination showed 100 (59.1%) cases with mucosal edema and 40 (23.6%) cases with segmental narrowing that came in consistence with previous study [21], as 42% of evaluated cases showed normal bronchoscopic inspection, while 32% of cases had unhealthy mucosa. On the other hand, Kumar et al. [11] found that edema with or without narrowing of a bronchial segment is present in 10 (7.5%) patients while mucus pooling, endobronchial nodules, and hyperemia in 6, 5, and 4 patients, respectively. The discrepancy of our results and aforementioned Kumar et al. study may be due to the criteria of cases selection, as all cases had changes in chest X-ray, which subsequently denotes corresponding changes in gross picture of fiber-optic bronchoscopy.

The present work reported 15.97% diagnostic yield of all FOB-associated technique for confirming TB diagnosis in patients with smear negative, which is considered as one of a lower diagnostic yield studies; however, the diagnostic yield of bronchoscopic procedures has ranged from 9 to 75% [11, 17, 22]. Chan et al. [23] study reported 14% diagnostic yield of FOB, as well as similar results reported by Russel et al. [24] and Khoo et al. [25], 12% and 9% respectively, while Palenque et al. [26] results showed a slightly higher yield; 34% of his cases were diagnosed as TB by FOB. On the other side, the studies with higher diagnostic yield were originated from India [17, 27,28,29], where the TB was endemic. The diagnostic yield was more than 45% of all examined cases.

The current data highlights the diagnostic utility of BAL examination by GeneXpert test; hence, beside the rapid interpretation of Xpert molecular test, its sensitivity and specificity were higher too, 81.25% and 95.42%, respectively. In study conducted by Walters et al. [30], to evaluate the potential role of GeneXpert on BAL samples, it include 40 cases, and the results revealed that BAL Xpert was positive in 7 (17.5%) cases with sensitivity of about 78%, which was close similar to our results. Moreover, Gowda et al. [31] examined the diagnostic utility of GeneXpert on BAL of patients with negative smear for TB and enrolled 60 patients. TB was confirmed by culture in 16 (26.7%) cases, with sensitivity and specificity of Xpert test reached to 81% and 73%, respectively in culture-confirmed cases. In the same line, Kilaru et al. [32] study the diagnostic role of GeneXpert in 56-suspected pulmonary TB cases with BAL samples; 17.8% of cases confirmed to have PTB based on culture. The sensitivity of Xpert test was closer to our results (90%), while the specificity was low (52.2%). This may be due to study design difference, as he considered all cases with positive Xpert or direct smear test of BAL sample plus the radiological changes as a possible TB case and subsequently sent for culture, in contrast with our study, since all BAL samples were subjected to TB culture evaluation from the start.

The strength of the present work rested on using acceptable sample size (169) that subjected to the same technique without selection baize, in addition to use GeneXpert test, which provide rapid results for decision-making for consequent treatment application.

In spite of different diagnostic facilities that were provided in our center, the study showed some limitations: the first of them was the study type; retrospective cohort, as, the research team data had been limited to which was accessible in record. The second limitation was neglecting the potential role of BAL collecting quality as well as the level of experience of bronchoscopist, which affected the results of all bacteriological tests.

Conclusion

GeneXpert test in bronchoalveolar lavage sample as well as on post bronchoscope sputum provided rapid results especially in cases with negative smear for TB, which could be enhanced by the significant decision for antituberculous treatment initiation.

References

  1. LoBue PA, Enarson DA, Thoen CO (2010) Tuberculosis in humans and animals: an overview [serialised article. Tuberculosis: are-emerging disease in animals and humans. Number 1 in the series]. Int J Tuberculosis Lung Dis. 14(9):1075–8

    CAS  Google Scholar 

  2. World Health Organization (2009) Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009. World health organization

  3. Gupta I, Guin P (2010) Communicable diseases in the South-East Asia Region of the World Health Organization: towards a more effective response. Bull World Health Organ 88:199–205

    Article  Google Scholar 

  4. Al-Harbie A, Sadek A, Picozzi K, Thrusfield M, Welburn SC (2016) Migration and related epidemiological risk factors associated with unavoidable increments of tuberculosis morbid indicators in Kuwait. Epidemiology (Sunnyvale) 6(257):2161–1165

    Google Scholar 

  5. Svensson E, Millet J, Lindqvist A, Olsson M, Ridell M, Rastogi N, Western Sweden Tuberculosis Epidemiology Study Group (2011) Impact of immigration on tuberculosis epidemiology in a low-incidence country. Clin Microbiol Infect. 17(6):881–7

    Article  CAS  Google Scholar 

  6. Behbehani N, Abal A, Al-Shami A, Enarson DA (2002) Epidemiology of tuberculosis in Kuwait from 1965 to 1999. Int J Tuberc Lung Dis 6(6):465–469

    Article  CAS  Google Scholar 

  7. World Health Organization (2010) Global tuberculosis control: key findings from the December 2009 WHO report. Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire 85(09):69-79.

  8. World Health Organization (2013) Global tuberculosis report 2013. World Health Organization

  9. Prakash P, Agarwal P, Agarwal P, Singh DP, Gupta A (2016) Role of bronchoscopy in diagnosing sputum smear negative pulmonary tuberculosis. Annals of Applied Bio-Sciences 3(1):A113-117

    Google Scholar 

  10. Service HK, Tuberculosis Research Centre M, Council BM (1981) A study of the characteristics and course of sputum smear-negative pulmonary tuberculosis. Tubercle. 62(3):155–67

    Article  Google Scholar 

  11. Kumar R, Singh M, Gupta N, Goel N (2014) Bronchoscopy in immediate diagnosis of smear negative tuberculosis. Adv Respiratory Med 82(5):410–414

    Article  Google Scholar 

  12. Pipatvech K, Kiatboonsri S, Boonsarngsuk V, Hongmanee P, Choothakan S (2007) The value of post-bronchoscopy sputum examination in the diagnosis of smear-negative pulmonary tuberculosis. Thai J Tuberculosis Chest Dis Crit Care 45-50.

  13. Kalawat U, Sharma KK, Reddy PN, Kumar AG (2010) Study of bronchoalveolar lavage in clinically and radiologically suspected cases of pulmonary tuberculosis. Lung India 27(3):122

    Article  Google Scholar 

  14. Prasad R, Singh A (2019) Role of bronchoscopy in diagnosis of smear-negative pulmonary tuberculosis. Egyptian J Bronchol 13(1):1–5

    Google Scholar 

  15. Kalawat U, Sharma KK, Reddy PN, Kumar AG (2010) Study of bronchoalveolar lavage in clinically and radiologically suspected cases of pulmonary tuberculosis. Lung India 27(3):122

    Article  Google Scholar 

  16. Tamura A, Shimada M, Matsui Y, Kawashima M, Suzuki J, Ariga H, Ohshima N, Masuda K, Matsui H, Nagai H, Nagayama N (2010) The value of fiberoptic bronchoscopy in culture-positive pulmonary tuberculosis patients whose pre-bronchoscopic sputum specimens were negative both for smear and PCR analyses. Intern Med 49(2):95–102

    Article  CAS  Google Scholar 

  17. Bachh AA, Gupta R, Haq I, Varudkar HG (2010) Diagnosing sputum/smear-negative pulmonary tuberculosis: does fibre-optic bronchoscopy play a significant role? Lung India 27(2):58

    Article  Google Scholar 

  18. Yassin MA, Cuevas LE (2003) How many sputum smears are necessary for case finding in pulmonary tuberculosis? Tropical Med Int Health 8(10):927–932

    Article  Google Scholar 

  19. Pinsky BA, Sahoo MK, Sandlund J, Kleman M, Kulkarni M, Grufman P, Nygren M, Kwiatkowski R, Baron EJ, Tenover F, Denison B (2015) Analytical performance characteristics of the Cepheid GeneXpert Ebola assay for the detection of Ebola virus. PLoS ONE 10(11):e0142216

    Article  Google Scholar 

  20. Della-Latta P (2004) Mycobacteriology and antimycobacterial susceptibility testing. Clinical microbiology procedures handbook

    Google Scholar 

  21. Purohit SD, Sisodia RS, Gupta PR, Sarkar SK, Sharma TN (1983) Fiberoptic bronchoscopy in diagnosis of smear negative pulmonary tuberculosis. Lung India 1(4):143

    Google Scholar 

  22. Quaiser S, Agarwal A, Khan R, Haque SF (2012) Fiberoptic bronchoscopy, as a valuable diagnostic option in sputum negative pulmonary tuberculosis: a prospective study. Int J Appl Basic Med Res 2(2):123

    Article  Google Scholar 

  23. Chan HS, Sun AJ, Hoheisel GB (1990) Bronchoscopic aspiration and bronchoalveolar lavage in the diagnosis of sputum smear-negative pulmonary tuberculosis. Lung 168(1):215–220

    Article  CAS  Google Scholar 

  24. Russell MD, Torrington KG, Tenholder MF (1986) A ten-year experience with fiberoptic bronchoscopy for mycobacterial isolation: impact of the Bactec system. Am Rev Respir Dis 133(6):1069–1071

    CAS  Google Scholar 

  25. Khoo KK, Meadway J (1989) Fibreoptic bronchoscopy in rapid diagnosis of sputum smear negative pulmonary tuberculosis. Respir Med 83(4):335–338

    Article  CAS  Google Scholar 

  26. Palenque E, Amor E, de Quiros JB (1987) Comparison of bronchial washing, brushing and biopsy for diagnosis of pulmonary tuberculosis. Eur J Clin Microbiol 6(2):191–192

    Article  CAS  Google Scholar 

  27. Sarkar SK, Sharma GS, Gupta PR, Sharma RK (1980) Fiberoptic bronchoscopy in the diagnosis of pulmonary tuberculosis. Tubercle 61(2):97–99

    Article  CAS  Google Scholar 

  28. Chawla R, Pant K, Jaggi OP, Chandrashekhar S, Thukral SS (1988) Fibreoptic bronchoscopy in smear-negative pulmonary tuberculosis. Eur Respir J 1(9):804–806

    Article  CAS  Google Scholar 

  29. Wongthim SO, Udompanich V, Limthongkul S, Charoenlap PR, Nuchprayoon CH (1989) Fiberoptic bronchoscopy in diagnosis of patients with suspected active pulmonary tuberculosis. J Med Assoc Thai 72(3):154–9

    CAS  Google Scholar 

  30. Walters E, Goussard P, Bosch C, Hesseling AC, Gie RP (2014) GeneXpert MTB/RIF on bronchoalveolar lavage samples in children with suspected complicated intrathoracic tuberculosis: a pilot study. Pediatr Pulmonol 49(11):1133–1137

    Article  Google Scholar 

  31. Gowda NC, Ray A, Soneja M, Khanna A, Sinha S (2018) Evaluation of Xpert® Mycobacterium tuberculosis/rifampin in sputum-smear negative and sputum-scarce patients with pulmonary tuberculosis using bronchoalveolar lavage fluid. Lung India 35(4):295

    Article  Google Scholar 

  32. Kilaru SC, Chenimilla NP, Syed U, Momin K, Kilaru H, Patil E, Nerurkar V (2019) Role of Xpert MTB/RIF in bronchoalveolar lavage fluid of sputum-scarce, suspected pulmonary TB patients. J Clin Tuberc Other Mycobact Dis 1(14):7–11

    Article  Google Scholar 

Download references

Acknowledgements

All team staff in Pulmonary Rehabilitation Center, Chest Hospital, Kuwait City, Kuwait

Funding

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by AA. The first draft of the manuscript was written by MAR and AA, and all authors commented on previous versions of the manuscript. The authors read and approved the final manuscript.

Corresponding author

Correspondence to Asmaa Ali.

Ethics declarations

Ethics approval and consent to participate

The study was approved by National Research Ethics Committee of Pulmonary Rehabilitation Center, Chest Hospital, Kuwait City, with reference number 1394/2020.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rakha, M.A., Ali, A., Hassan, W. et al. GeneXpert analysis of bronchoalveolar lavage (BAL) samples: promising diagnostic modality in patients with smear-negative pulmonary tuberculosis. Egypt J Bronchol 16, 68 (2022). https://doi.org/10.1186/s43168-022-00171-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43168-022-00171-5

Keywords